At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,714 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Massachusetts General Hospital Optical Coherence Tomography Registry
In Brief
An observational study for Coronary Artery Disease. Completed, enrolled 2,714 participants across 1 site.
Detailed Summary
Information will be collected prospectively in about 3,000 patients having Optical Coherence Tomography during cardiac catheterization. Subjects will be initially enrolled at sites outside of the United States, where Optical Coherence Tomography is approved by regulatory agencies. Subjects will be followed for up to 5 years.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesUnited States
CollaboratorsMedtronic, Boston Scientific Corporation, Massachusetts General Hospital
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartAug 2010
Primary CompletionApr 2019
TodayJul 2026
First PostedApr 26, 2010
Enrollment StartAug 1, 2010
Primary CompletionApr 1, 2019
TodayJul 2, 2026
Enrollment to primary: 8.7 yearsPosted 16.2 years ago